- MannKind Elder Abuse Is Replacing Inept CEO With Founder
- Has Obamacare Failed? 10 States With the Least Insurance Coverage
- Impeachment: The Only Option To Stop President Obama's Dangerous Foreign & Immigration Policies, Says FA Caucus
- ‘Very Negative’ Gold Sentiment Could Turn Market Around Sooner Than Expected – Analyst
- Will Apple Investors See Strong Returns in 2016?
Stocks turned green by mid-afternoon as rising tensions between Russia and Turkey pushed crude oil higher.
11/24/15 - 04:45 PM EST
Stocks moved higher in midday trading Monday, though cautiously after stellar gains last week marked the S&P 500's best five-day period of the year so far.
11/23/15 - 11:56 AM EST
U.S. stocks opened slightly lower as Wall Street digests one of the largest mergers in history.
11/23/15 - 10:01 AM EST
- Tickers in this article:
Does the mess around Dr. Reddy's make it a good buying opportunity
11/23/15 - 09:11 AM EST
Shares of biotech stocks have been volatile this year, but the sector is still outperforming the broader markets. Here's JPMorgan's top biotech picks coming out of earnings season.
11/21/15 - 01:15 PM EST
The last thing the biotech industry needs today is another hit to investor credibility. Clovis isn't helping.
11/21/15 - 11:30 AM EST
Not every stock is enjoying this rally, Cramer said, pointing out the troubles of BioMarion, Mentor Graphics and Nimble Storage. But overall, the market is looking relatively upbeat.
11/20/15 - 11:43 AM EST
It's almost cruel to see Al Mann being forced back into the CEO role at MannKind, but the company's near-total collapse demands it.
11/20/15 - 10:36 AM EST
The FDA is highly critical of BioMarin Pharmaceuticals' drisapersen, concluding that efficacy data from three clinical trials do 'not reach the level of substantial evidence' necessary for approval.
11/20/15 - 08:33 AM EST
Sick of watching those scary, sad drug ads during the game? So is the American Medical Association.
11/20/15 - 06:11 AM EST
The sector saw solid performance this week as the biotech juggernaut mounted a long-overdue rally.
11/19/15 - 02:30 PM EST
BioMarin will almost certainly be halted all day next Tuesday, so traders should watch Sarepta Therapeutics and PTC Therapeutics as proxies.
11/19/15 - 11:42 AM EST